Author + information
Background: Peripartum cardiomyopathy (PPCM) is an infrequent form of cardiomyopathy causing significant maternal morbidity and mortality. PPCM is diagnosed in women without a history of heart disease one month before delivery or within five months postpartum. This abstract is to assess the demographics of PPCM using the National Inpatient Sample (NIS) database for the year 2013.
Methods: Using NIS database (contains 20% of US hospitalizations), we were able to assess the following parameters on PPCM for 2013: number of discharges, insurance payers, location and teaching status of hospitals, hospital regions, mean length of stays (LOS) in hospitals and mean hospital charges (in dollars). We were also able to assess the trend of PPCM from 2003 to 2013.
Results: There were a total of 1450 discharges and 1430 women were in the age group between 18-44 years. Medicaid paid for 47.24%, private insurance paid for 44.83% of the discharges and the remaining were uninsured. 4.48% cases were treated in rural areas, 29.66% and 65.86% were treated in urban non-teaching and urban teaching hospitals respectively. 15.17% cases were from Northeast, 20.69% cases from Midwest, 52.41% cases from South and 11.72% of cases were from West. Mean charges in South hospitals were $70,649 and $35,809 in hospitals in the Western part. 37.59% of patients had low income. Mean LOS in hospital was 5.8 days and mean charges were $65,838. Overall, there were 302 cases of PPCM in 2003 which reached the maximum numbers in 2010 (1720 cases).
Conclusions: Greater than 60% of PPCM cases are handled by urban teaching hospitals. Greater than 50% cases are from the South due to unknown factors. LOS in hospitals is decreasing likely due to early diagnosis and better treatment options. Since the advent of separate diagnosis of ‘peripartum cardiomyopathy’, there has been close to 5 fold increase in the diagnosis in 2013 when compared to 2003 most likely due to better diagnostic modalities and guidelines. The mean cost of treating PPCM is 2.5 times more than the cost of treating heart failure in the elderly. Further studies need to be done to identify the cause for these cost differences.
Poster Hall, Hall C
Saturday, March 18, 2017, 9:45 a.m.-10:30 a.m.
Session Title: Advances in HCM, PPCM and Other Cardiomyopathies
Abstract Category: 13. Heart Failure and Cardiomyopathies: Clinical
Presentation Number: 1201-284
- 2017 American College of Cardiology Foundation